Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
Marcelo N. N. Vieira, Natalia M. Lyra e Silva, Sérgio T. Ferreira, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 103

Showing 26-50 of 103 citing articles:

True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedside
Yong Peng, Shun-yu Yao, Quan Chen, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102383-102383
Open Access | Times Cited: 7
Mulberry Leaf Compounds and Gut Microbiota in Alzheimer’s Disease and Diabetes: A Study Using Network Pharmacology, Molecular Dynamics Simulation, and Cellular Assays
Xue Bai, Xinyi Zhao, Kaifeng Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4062-4062
Open Access | Times Cited: 6
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
Pia Kivisäkk, Colin Magdamo, Bianca A. Trombetta, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 26
Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights
Bhawna Uprety, Heidi Abrahamse
Cells (2022) Vol. 11, Iss. 3, pp. 576-576
Open Access | Times Cited: 22
Discovery of a cryptic pocket in the AI-predicted structure of PPM1D phosphatase explains the binding site and potency of its allosteric inhibitors
Artur Meller, Saulo De Oliveira, Aram Davtyan, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 12
PTP1B knockdown alleviates BMSCs senescence via activating AMPK-mediated mitophagy and promotes osteogenesis in senile osteoporosis
Qiankun Yang, YuChi Zou, Xiaoyu Wei, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166795-166795
Closed Access | Times Cited: 12
Structural and molecular insights of protein tyrosine phosphatase 1B (PTP1B) and its inhibitors as anti-diabetic agents
Abhik Paul, Arnab Sarkar, Tanmoy Banerjee, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136258-136258
Closed Access | Times Cited: 11
Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia
Wenze Deng, Pengcheng Yi, Yanhong Xiong, et al.
Aging and Disease (2023) Vol. 15, Iss. 2, pp. 480-480
Open Access | Times Cited: 11
Alpha-Linolenic Acid Ameliorates Cognitive Impairment and Liver Damage Caused by Obesity
Xian Zhang, Jialu Bao, Yan Zhang, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 981-995
Open Access | Times Cited: 4
Analytical Methods for Assessing Thiol Antioxidants in Biological Fluids: A Review
Iuliia A. Poimenova, Madina M. Sozarukova, Daria-Maria V. Ratova, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4433-4433
Open Access | Times Cited: 4
Deciphering Potent Protein Tyrosine Phosphatase‐1B Inhibitors Through In silico Molecular Docking, MMGBSA, and Molecular Dynamics
Vishnu Malakar, Dhanabal Palanisamy, Bryan Gowramma, et al.
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders
Jiansong Fang, Li Gao, Huili Ma, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 39
Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?
Maud Gratuze, Aurélie Joly‐Amado, Didier Vieau, et al.
Neuroendocrinology (2018) Vol. 107, Iss. 2, pp. 181-195
Open Access | Times Cited: 35
Inhibition of protein tyrosine phosphatase 1B protects against sevoflurane-induced neurotoxicity mediated by ER stress in developing brain
Bin Liu, Guoyao Ou, Yali Chen, et al.
Brain Research Bulletin (2018) Vol. 146, pp. 28-39
Closed Access | Times Cited: 33
Protein Tyrosine Phosphatase (PTP1B): A promising Drug Target Against Life-threatening Ailments
Ajay Kumar, Divya Rana, Rajat Rana, et al.
Current Molecular Pharmacology (2019) Vol. 13, Iss. 1, pp. 17-30
Closed Access | Times Cited: 33
Overexpression of forebrain PTP1B leads to synaptic and cognitive impairments in obesity
Xing Ge, Minmin Hu, Menglu Zhou, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 456-470
Closed Access | Times Cited: 3
Design, synthesis, molecular docking and anticancer activity evaluation of methyl salicylate based thiazoles as PTP1B inhibitors
Dominika Kołodziej, Łukasz Sobczak, Wojciech Płaziński, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions
Tapas Kumar Mohapatra, Reena Rani Nayak, Ankit Ganeshpurkar, et al.
Ibrain (2025)
Open Access
Current Therapeutic Targets for Alzheimer's Disease
Amit Chaudhary, Pramod Kumar Maurya, Birendra Singh Yadav, et al.
Journal of Biomedicine (2018) Vol. 3, pp. 74-84
Open Access | Times Cited: 31
Neuroprotective Effects of Protein Tyrosine Phosphatase 1B Inhibition against ER Stress-Induced Toxicity
Yu‐Mi Jeon, Shinrye Lee, Seyeon Kim, et al.
Molecules and Cells (2017) Vol. 40, Iss. 4, pp. 280-290
Open Access | Times Cited: 29
Stilbenes with Potent Protein Tyrosine Phosphatase-1B Inhibitory Activity from the Roots of Polygonum multiflorum
Thi-Thuy An Nguyen, Mạnh Tuấn Hà, Se‐Eun Park, et al.
Journal of Natural Products (2020) Vol. 83, Iss. 2, pp. 323-332
Closed Access | Times Cited: 24
Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors
Bharti Devi, Sumukh Satyanarayana Vasishta, Bhanuranjan Das, et al.
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 649-669
Open Access | Times Cited: 9
Computer-aided identification of bioactive compounds from Gongronema latifolium leaf with therapeutic potential against GSK3β, PTB1B and SGLT2
Olusola Olalekan Elekofehinti
Informatics in Medicine Unlocked (2023) Vol. 38, pp. 101202-101202
Open Access | Times Cited: 8
Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine
Rosanna Maccari, Rosaria Ottanà
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9621-9621
Open Access | Times Cited: 8
Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer’s disease
Pourya Naderi Yeganeh, Sang Su Kwak, Mehdi Jorfi, et al.
Neuron (2024)
Closed Access | Times Cited: 3

Scroll to top